Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Aug;23(4):318-23.
doi: 10.1097/MED.0000000000000263.

Type B Insulin Resistance Syndrome


Type B Insulin Resistance Syndrome

Devina L Willard et al. Curr Opin Endocrinol Diabetes Obes. .


Purpose of review: To review the epidemiology, pathophysiology, clinical features, and management of type B insulin resistance syndrome.

Recent findings: Type B insulin resistance syndrome is a rare disorder caused by autoantibodies to the insulin receptor. This disorder is most frequently reported in middle-aged black women and is invariably associated with other autoimmune diseases. Typically, refractory transient hyperglycemia and extreme insulin resistance are the cardinal features, but hypoglycemia may also occur. Traditionally, the high reported mortality rate was typically attributed to the hypoglycemia. There is no well standardized treatment regimen. However, recent therapeutic advances with combination immunomodulatory therapy have led to significant reported improvements in hypoglycemia-associated mortality and durability of remission.

Summary: We review the literature on the pathophysiology and clinical features of type B insulin resistance syndrome and highlight the complexities and recent advances in the management of this disorder.

Similar articles

See all similar articles

Cited by 5 articles